MERTK and acute myeloid leukemia: We found that the AML cells exhibit increased expression of CD64, CD206, MARCO, CD163, CD11c, MerTK, and CD170, and reduced expression of CD11b, CD36, and HLA-DR compared to MDM (Fig. 6A through J; Fig. S5A).